journal
Journals Treatment Guidelines From the ...

Treatment Guidelines From the Medical Letter

https://read.qxmd.com/read/22996382/antimicrobial-prophylaxis-for-surgery
#21
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
October 2012: Treatment Guidelines From the Medical Letter
https://read.qxmd.com/read/22926426/drugs-for-chronic-heart-failure
#22
REVIEW
(no author information available yet)
No abstract text is available yet for this article.
September 2012: Treatment Guidelines From the Medical Letter
https://read.qxmd.com/read/22825657/antifungal-drugs
#23
REVIEW
(no author information available yet)
No abstract text is available yet for this article.
August 2012: Treatment Guidelines From the Medical Letter
https://read.qxmd.com/read/22777275/drugs-for-insomnia
#24
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
July 2012: Treatment Guidelines From the Medical Letter
https://read.qxmd.com/read/22777212/advice-for-travelers
#25
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
June 2012: Treatment Guidelines From the Medical Letter
https://read.qxmd.com/read/22538522/drugs-for-rheumatoid-arthritis
#26
REVIEW
(no author information available yet)
No abstract text is available yet for this article.
May 2012: Treatment Guidelines From the Medical Letter
https://read.qxmd.com/read/22450707/drugs-for-tuberculosis
#27
REVIEW
(no author information available yet)
The standard treatment for latent tuberculosis is nine months of isoniazid taken daily, or twice weekly under direct observation by a healthcare worker. Taking isoniazid and rifapentine once weekly for 12 weeks under direct observation is an alternative for patients >12 years old. Initial therapy for patients with active or suspected tuberculosis should include isoniazid, rifampin,pyrazinamide and ethambutol until susceptibility is known. In patients with drug-susceptible pulmonary tuberculosis, the continuation phase of treatment should be a combination of isoniazid and either rifampin or rifapentine, taken for 4 or 7 months depending on risk factors...
March 2012: Treatment Guidelines From the Medical Letter
https://read.qxmd.com/read/22361569/drugs-for-inflammatory-bowel-disease
#28
REVIEW
(no author information available yet)
No abstract text is available yet for this article.
March 2012: Treatment Guidelines From the Medical Letter
https://read.qxmd.com/read/22193287/drugs-for-hypertension
#29
REVIEW
(no author information available yet)
No abstract text is available yet for this article.
January 2012: Treatment Guidelines From the Medical Letter
https://read.qxmd.com/read/22113062/adult-immunizations
#30
REVIEW
(no author information available yet)
No abstract text is available yet for this article.
December 2011: Treatment Guidelines From the Medical Letter
https://read.qxmd.com/read/22033166/drugs-for-postmenopausal-osteoporosis
#31
REVIEW
(no author information available yet)
No abstract text is available yet for this article.
November 2011: Treatment Guidelines From the Medical Letter
https://read.qxmd.com/read/21941228/antithrombotic-drugs
#32
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
October 2011: Treatment Guidelines From the Medical Letter
https://read.qxmd.com/read/21860368/drugs-for-peptic-ulcer-disease-and-gerd
#33
REVIEW
(no author information available yet)
No abstract text is available yet for this article.
September 2011: Treatment Guidelines From the Medical Letter
https://read.qxmd.com/read/21778966/drugs-for-type-2-diabetes
#34
REVIEW
(no author information available yet)
No abstract text is available yet for this article.
August 2011: Treatment Guidelines From the Medical Letter
https://read.qxmd.com/read/21701443/drugs-for-irritable-bowel-syndrome
#35
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
July 2011: Treatment Guidelines From the Medical Letter
https://read.qxmd.com/read/21617596/drugs-for-hiv-infection
#36
REVIEW
(no author information available yet)
No abstract text is available yet for this article.
June 2011: Treatment Guidelines From the Medical Letter
https://read.qxmd.com/read/21519317/drugs-for-treatment-of-adhd
#37
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
May 2011: Treatment Guidelines From the Medical Letter
https://read.qxmd.com/read/21436767/diet-drugs-and-surgery-for-weight-loss
#38
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
April 2011: Treatment Guidelines From the Medical Letter
https://read.qxmd.com/read/21350395/drugs-for-lipids
#39
REVIEW
(no author information available yet)
No abstract text is available yet for this article.
March 2011: Treatment Guidelines From the Medical Letter
https://read.qxmd.com/read/21304447/drugs-for-migraine
#40
REVIEW
(no author information available yet)
No abstract text is available yet for this article.
February 2011: Treatment Guidelines From the Medical Letter
journal
journal
40275
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.